Use of Non-GAAP Financial Information Solid First Quarter Performance and Operating Execution 1 st Quarter 2024 Results May 9, 2024 Parth Mehrotra – Chief Executive Officer David Mountcastle – Chief Financial Officer ● 1Q'24 Performance Building One of the Largest 1 Forward-Looking Statements In order to provide investors with greater insight, promote transparency and allow for a more comprehensive understanding of the information used by management in its financial and operational decision-making, the Comp ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _________________________ FORM 10-Q _______________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-40365 _________________________ Privia Health Group, ...

Exhibit 99.1 Privia Health Reports First Quarter 2024 Financial Results – Practice Collections +7.4% compared to 1Q’23 – Implemented Providers +17.3% compared to 1Q’23 – Company Reiterated Full Year 2024 Guidance ARLINGTON, VA – May 9, 2024 – Privia Health Group, Inc. (Nasdaq: PRVA) today announced financial results for the first quarter ended March 31, 2024. For the Three Months Ended March 31, ($ in millions, except per share amounts) 2024 2023 Change (%) Total revenue $ 415.2 $ 386.3 7.5 % Gross profit $ ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _________________________ FORM 10-K _______________________________ (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the year ended December 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-40365 _________________________ Privia Health Group, Inc. (Exact ...

Privia Health Group, Inc. (NASDAQ:PRVA) Q4 2023 Earnings Conference Call February 27, 2024 8:00 AM ET Company Participants Robert Borchert - SVP, Investor & Corporate Communications Parth Mehrotra - President and CEO David Mountcastle - CFO Conference Call Participants Joshua Raskin - Nephron Research Unidentified Analyst - Jefferies Lisa Gill - J.P. Morgan Jack Senft - William Blair Sameer Patel - Evercore ISI David Larsen - BTIG Jessica Tassan - Piper Sandler Gary Taylor - TD Cowen Richard Close - Canacco ...

| --- | --- | --- | --- | --- | |----------------------------------------------------------------------------------------|-------------------------------------------------|-------|-------|-------| | | | | | | | | | | | | | 4 th Quarter 2023 Results February 27, 2024 Parth Mehrotra – David Mountcastle – | Chief Executive Officer Chief Financial Officer | | | | 1 Disclaimer Forward-Looking Statements This presentation contains forward-looking statements that express the Company's opinions, expectations, belie ...

Exhibit 99.1 Privia Health Reports Fourth Quarter and Full-Year 2023 Financial Results ARLINGTON, VA – February 27, 2024 – Privia Health Group, Inc. (Nasdaq: PRVA) today announced financial and operating results for the fourth quarter and full year ended December 31, 2023. The Company achieved each of its full- year guidance metrics for 2023, as highlighted below. Full-Year Performance | | | | For the Years Ended December 31, | | | | --- | --- | --- | --- | --- | --- | | ($ in millions, except per share amo ...

Privia Health Group, Inc (NASDAQ:PRVA) Q3 2023 Earnings Call Transcript November 3, 2023 9:00 AM ET Joshua Raskin - Nephron Research Elizabeth Anderson - Evercore ISI Jailendra Singh - Truist Securities Richard Close - Canaccord Genuity Brian Tanquilut - Jefferies Adam Ron - Bank of America Jack Senft - William Blair Benjamin Mayo - Leerink Partners Jeffrey Garro - Stephens Inc. Gary Taylor - Cowen Inc Jamie Perse - Goldman Sachs Jessica Tassan - Piper Sandler David Larsen - BTIG Robert Borchert Parth Mehro ...

3 rd Quarter 2023 Results November 3, 2023 Parth Mehrotra – Chief Executive Officer David Mountcastle – Chief Financial Officer 1 Disclaimer Forward-Looking Statements Use of Non-GAAP Financial Information In order to provide investors with greater insight, promote transparency and allow for a more comprehensive understanding of the information used by management in its financial and operational decision-making, the Company supplements its condensed consolidated financial statements presented on a GAAP basi ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _________________________ FORM 10-Q _______________________________ (Mark One) For the quarterly period ended September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-40365 _________________________ Privia Health Group, Inc. (Exact Name of Registrant as Specified in Its Charter) _________________________ ...